Advertisement.

HBPCF Projected Dividend Yield

Helix BioPharma Corp ( OTCBB : HBPCF )

Helix BioPharma Corp. is a biopharmaceutical company specializing primarily in the field of cancer therapy. Co. is engaged in developing innovative products for the treatment and prevention of cancer based on its proprietary technologies. Co.'s product development initiatives are focused primarily on its L-DOS47 and Topical Interferon Alpha-2b drugs. In addition, Co. distributes Orthovisc® and MonoviscTM , treatments for osteoarthritis of the knee; Normacol® and Klean-Prep™, gastrointestinal products; and Imunovir™, an immune system modulating drug in Canada.

20 YEAR PERFORMANCE RESULTS

HBPCF Dividend History Detail
HBPCF Dividend News
HBPCF Competitors News

# of Shares: 0

Closing Price: 0.45

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000